Anne Samuel
Stock Analyst at JP Morgan
(2.43)
# 2,474
Out of 5,140 analysts
67
Total ratings
52.27%
Success rate
0.09%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Overweight | $13 → $7 | $3.80 | +84.21% | 13 | Nov 17, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $125 → $126 | $84.59 | +48.95% | 9 | Sep 3, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $274 → $290 | $219.73 | +31.98% | 7 | Aug 28, 2025 | |
| PGNY Progyny | Maintains: Neutral | $23 → $25 | $25.45 | -1.77% | 8 | Aug 26, 2025 | |
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $39.85 | +50.56% | 7 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $241.40 | -26.68% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $50.48 | -28.68% | 5 | Mar 20, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $15.62 | +79.26% | 2 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $21.56 | -2.57% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $2.30 | +465.22% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $29.56 | -8.66% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $2.38 | +110.08% | 1 | Jul 31, 2024 |
Evolent Health
Nov 17, 2025
Maintains: Overweight
Price Target: $13 → $7
Current: $3.80
Upside: +84.21%
HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125 → $126
Current: $84.59
Upside: +48.95%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274 → $290
Current: $219.73
Upside: +31.98%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23 → $25
Current: $25.45
Upside: -1.77%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $39.85
Upside: +50.56%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $241.40
Upside: -26.68%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $50.48
Upside: -28.68%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $15.62
Upside: +79.26%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $21.56
Upside: -2.57%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $2.30
Upside: +465.22%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $29.56
Upside: -8.66%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $2.38
Upside: +110.08%